Irinotecan EP Impurity C TFA - Solicitar cotización

Irinotecan EP Impurity C TFA is chemically (4S)-4,8,11-triethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl 1,4′-bipiperidine-1′-carboxylate ,2,2,2-trifluoroacetate (as per EP) ; (S)-4,8,11-Triethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quin oline-3,14(4H,12H)-dione-9-yl (1,4′-bipiperidine)-1′-carboxylate Trifluoroacetate (as per USP). Irinotecan EP Impurity C TFA is supplied with detailed characterization data compliant with regulatory guideline. Irinotecan EP Impurity C TFA can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Irinotecan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.